Vladimir Aleksandrovich Rudnov

Vladimir Aleksandrovich Rudnov

Auto-generated profile, based on publicly available information

Vladimir Aleksandrovich Rudnov

Ural State Medical University

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
TFThomas M. File
Thomas M. File
DLDonald E. Low
Donald E. Low
PEPaul B. Eckburg
Paul B. Eckburg
GTGeorge H. Talbot
George H. Talbot
HFH. David Friedland
H. David Friedland
JPJan Plutinsky
Jan Plutinsky
Ceftaroline, the active form of the prodrug ceftaroline fosamil, is a novel cephalosporin with bactericidal activity against important pathogens associated with community-acquired pneumonia (CAP), including Streptococcus pneumoniae and common Gram-negative pathogens. FOCUS 1 is a randomized, double-blinded, Phase III study that was conducted to evaluate the efficacy and safety of ceftaroline fosamil in treating patients with CAP. The primary objective was to determine non-inferiority [lower limit of 95% confidence interval (CI) ≥ −10%] in clinical cure rates achieved with ceftaroline fosamil compared with those achieved with ceftriaxone in the clinically evaluable (CE) and modified intent-to-treat efficacy (MITTE) populations. Patients hospitalized in a non-intensive care unit setting with CAP of Pneumonia Outcomes Research Team (PORT) risk class III or IV requiring intravenous (iv) therapy were randomized (1:1) to receive 600 mg of ceftaroline fosamil iv every 12 h or 1 g of ceftriaxone iv every 24 h. Patients also received two 500 mg doses of oral clarithromycin every 12 h administered on day 1. Clinical cure, microbiological response, adverse events (AEs) and laboratory tests were assessed. FOCUS 1 registration number NCT00621504 (http://clinicaltrials.gov/ct2/show/NCT00621504). Of 613 enrolled patients, 298 received ceftaroline fosamil and 308 received ceftriaxone. Baseline characteristics between treatment groups were comparable. Clinical cure rates were as follows: CE population, 86.6% (194/224) for ceftaroline fosamil and 78.2% (183/234) for ceftriaxone [difference (95% CI), 8.4% (1.4, 15.4)]; and MITTE population, 83.8% (244/291) for ceftaroline fosamil and 77.7% (233/300) for ceftriaxone [difference (95% CI), 6.2% (−0.2, 12.6)]. Clinical cure rates for CAP caused by S. pneumoniae in the microbiological MITTE population were 88.9% (24/27) and 66.7% (20/30) for ceftaroline fosamil and ceftriaxone, respectively. Both agents were well tolerated, with similar rates of AEs, serious AEs, deaths and discontinuations because of an AE. The most common AEs for ceftaroline fosamil-treated patients were diarrhoea, headache, insomnia and nausea, and the most common AEs for ceftriaxone-treated patients were hypokalaemia, hypertension, nausea and diarrhoea. Ceftaroline fosamil demonstrated high clinical cure and microbiological response rates in hospitalized patients with CAP of PORT risk class III or IV. Ceftaroline fosamil was well tolerated, with a safety profile similar to that of ceftriaxone and consistent with the cephalosporin class. In this study, ceftaroline fosamil was an effective and well-tolerated treatment option for CAP.

13 July 2022 in PULMONOLOGIYA
Verified
Journal Article
Closed access
PDF file
SASergey Avdeev
Sergey Avdeev
ADA. V. Dekhnich
A. V. Dekhnich
AZA. A. Zaytsev
A. A. Zaytsev
Roman KozlovRoman Kozlov
Roman Kozlov
Svetlana RachinaSvetlana Rachina
Svetlana Rachina
ACAlexander Chuchalin
Alexander Chuchalin
Community-acquired pneumonia is one of the most common acute infectious diseases that has a significant share in the structure of mortality from respiratory diseases. It is extremely important to select rational antibiotic therapy which ensures optimal clinical efficacy, improved outcome, reduced rate of antibiotic resistance selection, and minimization of side effects.Methods. The target audience of these clinical recommendations are therapists, general practitioners, pulmonologists, anesthesiologist-resuscitators, and clinical pharmacologists. Each thesis-recommendation about diagnostic and therapeutic procedures has been scored according to the scale of classes of recommendations from 1 to 5 and A, B, C scale of the levels of evidence. The clinical recommendations also contain comments and explanations to these theses, algorithms for the diagnosis and treatment, and reference materials on the use of antibacterial drugs and microbiological (culture) tests.Conclusion. The presented clinical guidelines cover current information about the etiology, clinical manifestations, diagnosis and treatment tactics for community-acquired pneumonia. The presented clinical guidelines have been approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation in 2021.

30 October 2023 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
MKMikhail Kirov
Mikhail Kirov
ВКВ. В. Кузьков
В. В. Кузьков
DPD. N. Protsenko
D. N. Protsenko
ASA. V. Shchegolev
A. V. Shchegolev
MBMAXIM BABAEV
MAXIM BABAEV
IZI. B. Zabolotskikh
I. B. Zabolotskikh
The paper represents the clinical guidelines for septic shock in adults, approved by the All-Russian public organization “Federation of anesthesiologists and reanimatologists” in 2023. Septic shock is a widespread condition with a high mortality rate. The recommendations cover the issues of etiology, pathogenesis, clinical signs and symptoms, methods of laboratory and instrumental diagnosis of septic shock. The clinical guidelines present initial therapy for septic shock, including approaches to vasopressor and inotropic therapy, recommendations for choosing antibacterial drugs, fluid and adjuvant therapy. The issues of surgical treatment of the infection are discussed. The article contains the criteria for the quality of medical care for the adult patients with septic shock and algorithms for the decision making in the diagnosis and intensive care of patients with septic shock.

29 April 2022 in Annals of Critical Care
Verified
Journal Article
Open access
ABAndrey A. Belkin
Andrey A. Belkin
AAA. M. Alasheev
A. M. Alasheev
VBV. A. Belkin
V. A. Belkin
YBY. B. Belkina
Y. B. Belkina
ABAnna Belova
Anna Belova
SNS. N. Norvils
S. N. Norvils
After discharge from the Intensive Care Unit (ICU), more than 50 % of patients experience pathological symptoms that are not related to the primary emergency but reduce the quality of life and require rehabilitation. Post Intensive Care Syndrome (PIСS) include only those conditions that do not have a direct causal relationship with the emergency condition that gave rise to hospitalization in the ICU. The pathophysiological basis of the PICS is the phenomenon of “learned non-use”: a state of artificial limitation of the patient’s motor and cognitive activity as a result of the use of analgosedation, bed rest and immobilization. The clinical picture of PICS is determined by the severity of its individual components, detailed using a package of clinimetric scales. Based on the results of dynamic testing, the PICS severity index is calculated. The sum of the scores in the range from 0 to 10 reflects the severity and effectiveness of rehabilitation measures. For the prevention of PICS, the Union of Rehabilitologists of Russia together with the Federation of Anesthesiologists and Resuscitators of Russia has developed the rehabilitation complex “ReabICU”. In the English-language literature, such a complex is called “Awakening and Breathing Coordination, Delirium monitoring/management, and Early exercise/mobility” bundle. ReabICU is a complex of technologically therapeutic and diagnostic modules “positioning and mobilization”, “prevention of dysphagia and nutritional deficiency”, “prevention of emotional and cognitive impairment and delirium”, “prevention of loss of self-care skills”. The basis of the multidisciplinary rehabilitation team, which includes a doctor for medical rehabilitation, 2 specialists in physical rehabilitation, a specialist in occupation therapy, a medical psychologist, a medical speech therapist, a nurse for medical rehabilitation. The activity of multidisciplinary rehabilitation team is evaluated on the basis of quality criteria and the achievement of the main goal of ReabICU — the preservation of the premorbid status of the patient’s socialization.

21 February 2025 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
SBS. F. Bagnenko
S. F. Bagnenko
EGE. S. Gorobets
E. S. Gorobets
VGV. G. Gusarov
V. G. Gusarov
ADA. V. Dekhnich
A. V. Dekhnich
MDM. D. Dibirov
M. D. Dibirov
SYS. V. Yakovlev
S. V. Yakovlev
Clinical guidelines «Sepsis (in adults)» are an interdisciplinary document developed by 8 professional non-profit public organizations and approved by the Scientific and Practical Council of the Ministry of Health of Russia. They are intended to help doctors of various specialties (anesthesiologist and intensivist, surgeon, emergency physician, neurosurgeon, cardiovascular surgeon, thoracic surgeon, transfusiologist, orthopedic traumatologist, nephrologist, urologist, maxillofacial surgeon, infectious disease physician, clinical pharmacologist, medical microbiologist) in determining the treatment strategy and tactics for patients with sepsis or at risk of its development. The material presented to the reader’s attention reflects the main provisions of the document that are important for practical work. Its full content can be found on the websites of the Ministry of Health (https://cr.minzdrav.gov. ru/) and the public organizations (in particular, https://association-ar.ru/; https://общество-хирургов.рф/; https://sepsisforum.ru/; https://www. antibiotic.ru/) that developed them. In terms of their main provisions, the recommendations correspond to the latest international guidelines (Surviving sepsis campaign from 2021), but take into account the specifics of the work of medical organizations in the Russian Federation. These recommendations apply to the following codes of the International statistical classification of diseases and problems related to adult health: A40 – streptococcal sepsis (A40.0/A40.1/A40.2/A40.3/A40.8/A40.9); A41 – other sepsis (A41.0/A41.1/A41.2/A41.3/A41.4/A41.5/A41.8/41.9) and B37.7 – candidal septicemia.

23 May 2018 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
ZKZ. Т. Kotvitskаya
Z. Т. Kotvitskаya
GKG. B. Kolotovа
G. B. Kolotovа
VRV. А. Rudnov
V. А. Rudnov
VBVladimir Bagin
Vladimir Bagin
Цель исследования: установить интраоперационные факторы риска развития инфаркта миокарда в периоперационном периоде у некардиохирургических пациентов. Материалы и методы. Проведен ретроспективный анализ 85 историй болезни пациентов, у которых после оперативных (некардиохирургических) вмешательств в послеоперационном периоде развился инфаркт миокарда. Проанализированы клинико-электрокардиографические параметры, исходы периоперационного инфаркта миокарда и интраоперационные факторы риска его развития. Группу сравнения составили 80 оперированных пациентов с благоприятным течением послеоперационного периода. Результаты: инфаркт миокарда в послеоперационном периоде в 72,9% случаев развивался в 1-е сут и характеризовался стертостью клинических проявлений: у 23,5% он протекал без болевого синдрома, в 69,4% случаев − без подъема сегмента ST на ЭКГ. Факторами риска развития инфаркта миокарда в послеоперационном периоде являлись: длительность операции более 90 мин, интраоперационная гипотензия (АДсист < 100 мм рт. ст.) продолжительностью более 10 мин, анемия с уровнем гемоглобина менее 70 г/л, частота сердечных сокращений в периоперационном периоде более 90 уд./мин. В результате логистического многофакторного анализа установлено, что независимым фактором риска развития инфаркта миокарда в послеоперационном периоде явилось только снижение систолического артериального давления менее 100 мм рт. ст. – ОШ 4,24 (1,181−15,20), p = 0,026.